52025-76-0C=C(C)[C@@H]1CC[C@](C)(O)[C@H]2Oc3cc(CCCCC)cc(O)c3[C@@H]12RBEAVAMWZAJWOI-MTOHEIAKSA-Ncannabielsoin has been reported in Cannabis sativa with data available.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
CDFs cause vomiting and diarrhea, anemia, more frequent lung infections, numbness and other effects on the nervous system, and mild changes in the liver. However, there were no permanent liver changes or definite liver damage found in people who ingested CDFs. (L952)
No information on the metabolism of dibenzofuran in mammalian organisms was found in the available literature. The bacteria Sphingomonas, Brevibacterium, Terrabacter, and Staphylococcus auricularis degrade dibenzofuran to 2,2',3-trihydroxybiphenyl via dibenzofuran 4,4a-dioxygenase. (L952)
DescriptionCannabielsoin (CRM) (Item No. 36661) is a certified reference material categorized as a phytocannabinoid metabolite.1,2 Cannabielsoin is a metabolite of cannabidiol (CBD; Item Nos. ISO60156 | 90080). This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use.
Loading…
Loading…
No reaction records under the current filter.
Loading…
52025-76-0DTXSID50966364